Get Articles Daily from StraightStocks - Enter Email Address


  • National Debt Clock




ProtoKinetix Receives European Proposals (OTC:PKTX)

Source: http://feedproxy.google.com/~r/FavStocks/~3/DHuLTQUgpaQ/
Posted on Wednesday, December 16th, 2009 | In Market Commentary, Stocks to Watch
Contributed by: Jyotsna Ramani (http://www.favstocks.com) -

ProtoKinetix Inc (OTC:PKTX) has announced that they have recently been approached by a European biopharma investment group with a series of proposals for development of commercial partnerships in the areas like pharmaceuticals and cosmetics. Hence, in order to support these new developments it has been strongly suggested that their European technology better known as AAGP should be showcased within the European community. This would also include an awareness program leading up to a sponsorship for a listing on the AIM, London Stock Exchange.


ProtoKinetix Inc is one of the leading biopharmaceutical companies that have been into the development of medicines for many biotechnology and cosmetics industries. The Company has also patented a family of synthetic anti-aging glycoproteins (AAGP). Currently, the Company is in dialogue with many major corporations and institutions that have approached ProtoKinetix with a series of proposals about the broad range of applications for AAGP products. CEO and President of ProtoKinetix, Ross Senior, said that the proposals are currently being evaluated and that they are happy the Company has received a number of excellent opportunities to enter into new collaborations which will help them expand the use and applications of their AAGP technology.

He further mentioned that they will soon declare the results of their evaluations and that such European collaborations and proposals will surely give them more confidence to be successful both scientifically and financially. The AAGP technology used by ProtoKinetix has been successfully evaluated in laboratories in France and University of Bordeaux which proved that the molecules were non-toxic in standard concentrations.

Last 5 posts by Jyotsna Ramani





About Jyotsna Ramani (http://www.favstocks.com)
Joyotsna has completed Post Graduation in Tourism from College of Vocational Studies apart from a full time MBA degree in Finance. She has worked with several reputed companies including IBM. Currently, she is a SAHM, earning a living off trading in the stock market and forex.

Leave a Reply

Name

Email (kept private)

Website












No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.